Is thyroid cancer prognosis affected by solid organ transplantation?

Webb, Christopher; Cronin, Patricia A.; Gupta, Nikita; Verhey, Jens T.; Calderon, Esteban; Moss, Adyr; Mathur, Amit K.; Pockaj, Barbara A.; Wasif, Nabil; Stucky, Chee Chee H.

doi:10.1016/j.surg.2020.06.044

Cited by 3 publications

(2 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The evaluation for thyroid disease concurrent with kidney-related HPT should be the same as for patients without parathyroid disease. The incident and prognosis of thyroid cancers in the patients undergoing solid-organ transplant is similar to the general population 150–152. In patients with kidney-related HPT, the presence of thyroid cancer or thyroid nodules should not preclude kidney transplant.…”

Section: Imagingmentioning

confidence: 97%

“…The incident and prognosis of thyroid cancers in the patients undergoing solid-organ transplant is similar to the general population. [150][151][152] In patients with kidney-related HPT, the presence of thyroid cancer or thyroid nodules should not preclude kidney transplant. Evidence-based guidelines, such as those published by the American Association of Endocrine Surgeons or the American Thyroid Association, should be followed for the management of concurrent thyroid disease.…”

Section: Concurrent Thyroid Diseasementioning

confidence: 99%

See 1 more Smart Citation

The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Secondary and Tertiary Renal Hyperparathyroidism

Dream

Kuo

et al. 2022

Annals of Surgery

View full text Add to dashboard Cite

Objective: To develop evidence-based recommendations for safe, effective, and appropriate treatment of secondary (SHPT) and tertiary (THPT) renal hyperparathyroidism. Background: Hyperparathyroidism is common among patients with chronic kidney disease, end-stage kidney disease, and kidney transplant. The surgical management of SHPT and THPT is nuanced and requires a multidisciplinary approach. There are currently no clinical practice guidelines that address the surgical treatment of SHPT and THPT. Methods: Medical literature was reviewed from January 1, 1985 to present January 1, 2021 by a panel of 10 experts in SHPT and THPT. Recommendations using the best available evidence was constructed. The American College of Physicians grading system was used to determine levels of evidence. Recommendations were discussed to consensus. The American Association of Endocrine Surgeons membership reviewed and commented on preliminary drafts of the content. Results: These clinical guidelines present the epidemiology and pathophysiology of SHPT and THPT and provide recommendations for work-up and management of SHPT and THPT for all involved clinicians. It outlines the preoperative, intraoperative, and postoperative management of SHPT and THPT, as well as related definitions, operative techniques, morbidity, and outcomes. Specific topics include Pathogenesis and Epidemiology, Initial Evaluation, Imaging, Preoperative and Perioperative Care, Surgical Planning and Parathyroidectomy, Adjuncts and Approaches, Outcomes, and Reoperation. Conclusions: Evidence-based guidelines were created to assist clinicians in the optimal management of secondary and tertiary renal hyperparathyroidism.

show abstract

Section: Imagingmentioning

confidence: 97%

Section: Concurrent Thyroid Diseasementioning

confidence: 99%